The current institutional shareholding score of Evolus Inc is 7.00, ranking 51 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 75.98%, representing a quarter-over-quarter decrease of 14.84%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.51% of shares outstanding, with 0.93% decrease in holdings.